Susquehanna Fundamental Investments’s Checkpoint Therapeutics CKPT Stock Holding History

Susquehanna Fundamental Investments’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-26,334	Closed	-$106K	–	776
2025 Q1	$106K	Buy	+26,334	New	+$87.8K	﹤0.01%	1028

Susquehanna Fundamental Investments's CKPT Position: Q2 2025 in Review

Susquehanna Fundamental Investments sold out of Checkpoint Therapeutics (CKPT) in Q2 2025, closing a stake of 26,334 shares — an estimated $106K sold.

Susquehanna Fundamental Investments first reported a position in CKPT in Q1 2025 and held it in 1 quarter. The position peaked at $106K in Q1 2025. 0 funds tracked by Wall St. Rank hold CKPT as of Q2 2025.

Susquehanna Fundamental Investments reported no remaining Checkpoint Therapeutics position as of Q2 2025 after selling out during the quarter.
Susquehanna Fundamental Investments sold 26,334 Checkpoint Therapeutics shares in Q2 2025, an estimated $106K.
Susquehanna Fundamental Investments first reported a position in Checkpoint Therapeutics in Q1 2025 and held it in 1 quarter.
Susquehanna Fundamental Investments's Checkpoint Therapeutics position peaked at $106K in Q1 2025.
0 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q2 2025.

Based on Susquehanna Fundamental Investments's 13F filing for Q2 2025, filed 14 Aug 2025.